INTRODUCTION
Bladder cancer is a common urologic cancer prevailing in Korea [1] . Early detection of bladder cancer is critical to improve the survival rate. Although cystoscopy is the gold standard for detection of bladder cancer, the development of noninvasive serologic or urinary biomarkers would greatly aid in the diagnosis or treatment of bladder cancer.
The human apyrimidinic endonuclease 1/redox factor-1 (APE1/Ref-1) gene is located on chromosome 14q11-12, and encodes a 318 aa long protein with a molecular weight of 36 kDa [2] . APE1/Ref-1 plays an important role in DNA repair and redox regulation. The C-terminus of APE1/Ref-1 is involved in DNA repair as an apurinic/apyrimidinic endonuclease. In contrast, the N-terminus is involved in redox regulation as a reducing donor to cysteine residues, leading to the modulation of transcriptional factors, such as activator protein-1 and nuclear factor-kappa B, and antioxidant activity [3] . Oxidative stress, tobacco exposure, and/or environmental chemicals can induce DNA damage, leading to tumorigenesis in human tissues. APE1/Ref-1 plays an important role against oxidative or environmental DNA damage. APE1/Ref-1 genetic variation is closely linked to cancer pathogenesis or susceptibility [4] . Single nucleotide polymorphism analyses show that APE1/Ref-1 polymorphisms may contribute to an increased risk of bladder cancer [5, 6] .
The APE1/Ref-1 protein level is increased in the serum and urine of patients with bladder cancer [7, 8] , which can be useful for the diagnosis of bladder cancer. Increased APE1/Ref-1 levels are associated with the tumor stage and grade of bladder cancer, suggestive of being a reliable biomarker of bladder cancer [7, 8] . The precise mechanism underlying the existence of serum or urinary APE1/Ref-1 in patients with bladder cancer is still unknown. However, secretion of APE1/Ref-1 is closely related with intracellular acetylation [9] [10] [11] .
Therefore 
MATERIALS AND METHODS

Reagents
Trichostatin A (TSA), Ponceau S, 4ʹ,6-diamidino-2-phenylindole (DAPI), and fluorescence mounting solution were purchased from Sigma-Aldrich (St. Louis, MO, USA). Dulbecco's modified Eagle's medium (DMEM) was purchased from Welgene (Seoul, Korea). Fetal bovine serum, antibiotics, Opti-MEM, methanol-free paraformaldehyde, and transfection reagent, Lipofectamine LTX with Plus were purchased from Thermo Fisher Scientific (Waltham, MA, USA). Antibodies against FLAG and β-actin were purchased from Sigma-Aldrich. 
Cell Culture and Transfection
The human embryonic kidney epithelial 293T (HEK293T) cell line was purchased from the American Type Culture Collection (Manassas, VA, USA). Cells were grown in DMEM (Welgene) containing 10% fetal bovine serum (Thermo Fisher Scientific) and 1% antibiotics. Cells were maintained in a humidified atmosphere of 95% air and 5% CO2, at 37°C. For transient transfection, HEK293T cells were seeded in plates at a density of 2. 
Determination of Cell Viability
Cell viability was determined using propidium iodide staining and an automatic cell counter (ADAM-MC), as previously described [9] .
Measurement of Secreted APE1/Ref-1
A sandwich enzyme-linked immunosorbent assay (ELISA) was used to quantify the level of secreted APE1/Ref-1 in the culture medium (CM), as previously described [11] .
Immunoprecipitation
HEK293T cells were grown to confluence on a 6-well plate (5 × 10 5 cells/well) and then treated with 1μM TSA for 1 hour after changing the CM. The CM was collected at different time points and centrifuged at 1,200 rpm for 3 minutes to remove the residual cells. The supernatant was again centrifuged at 3,000 rpm for 3 minutes. The APE1/Ref-1 in the CM was immunoprecipitated using anti-APE1/Ref-1 antibody as previously reported [10] . The immune complexes were mixed with sample buffer and subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) followed by immunoblotting.
Immunoblotting
Whole cell lysates were prepared as previously described [11] .
The cell lysates were cleared by centrifugation at 14,000 × g for 15 minutes, and the supernatant fraction was used for immunoblotting. Proteins were resolved by SDS-PAGE and transferred onto a polyvinylidene difluoride membrane. After blocking with 5% nonfat dry milk in Tris-buffered saline (TBS) containing 0.05% Tween 20, the membrane was incubated with the desired primary antibody overnight at 4°C. The membrane was then washed and probed with the appropriate secondary antibody, and the immunoreactive bands were visualized by an enhanced chemiluminescence method. Each membrane was stripped and reprobed with antiactin antibody to ensure equal protein loading. 
Subcellular Localization of APE1/Ref-1 Variants
Statistical Analysis
All data are expressed as the mean ± standard error of the mean. Statistical significance of differences in measured variables was determined using one-way analysis of variance followed by Bonferroni test for multiple comparisons. Differences were considered significant at P < 0.05.
RESULTS
Identification of APE1/Ref-1 Gene Variants in Patients With
Bladder Cancer A > G were observed without amino acid changes in 2 specimens. Noticeably, the genotype with D148E was observed in 6 specimens with single or double mutations (Table 1) . 
Protein Expression and Localization of
Kinetics of Secreted APE1/Ref-1 D148E Variants
Given that the secretion of D148E in APE1/Ref-1 was clearly distinct from other secretions, we directly compared the secreted amount of wild-type and D148E variants in CM for 1 hour after changing media, as represented in Fig. 3A (upper) . The secretion level of the wild-type APE1/Ref-1 protein reached 0.15 ng/mL in 1 hour, whereas that of the D148E mutants showed a drastic increase to 0.65 ng/mL in the same amount of time, suggesting a high secretory activity of D148E mutants even in the absence of any stimulus (Fig. 3A bottom) . Next, degradation kinetics of secreted APE1/Ref-1 D148E mutants were studied and evaluated for 6 hours in cell-free medium after stimulation with TSA for 1 hour. Nonlinear fit regression analysis showed that the half-life for degradation of the secreted wild-type and D148E was not significantly different (half-life of 1.6 hours for wild-type and 1.8 hours for D148E) in cell-free CM (Fig. 3B) . Collectively, these results suggest that the increased levels of APE1/Ref-1 in the D148E variant might be due to increased secretory activity, rather than the delayed degradation of D148E.
DISCUSSION
In the present study, we identified 4 distinct APE1/Ref-1 variants: one with a single substitution mutation in D148E and 3 with double substitution mutations in I64V/D148E, W67R/ D148E, and E86G/D148E in bladder tissue specimens from patients with bladder cancer. Using DNA recombination technology, all substitution mutations identified in bladder cancer were subcloned, and their functional role on the secretion of APE1/ Ref-1 was evaluated.
Risk factors such as cigarette smoking and chronic exposure to toxic environmental chemicals play key roles in the tumorigenesis of bladder cancer [13] . DNA damage on single-strand breaks is mainly repaired with base excision repair proteins like APE1/Ref-1 [14] . Genetic variation of APE1/Ref-1 is associated with the risk of cancer. Among the genetic variations, the single substitution D148E has been extensively investigated in association with different types of cancer, such as lung, breast, gastric, and bladder cancers [5, [15] [16] [17] . is not yet known, there are some hypotheses regarding the subject. In silico analyses indicate that the Asp148Glu substitution may cause changes in the protein structure and is associated with an increased risk of breast cancer [20] . The target amino acid at position 148 of the APE1/Ref-1 protein was mutated from Asp to Glu and selected for the lowest energy conformations [20] . The D148E polymorphism of APE1/Ref-1 is related to reduced base excision repair efficiency, which is potentially linked with genomic instability [21] . In addition, the amino acid substitutions may alter the redox function of APE1/Ref-1. Therefore, this genomic instability and/or alteration of redox function, such as changes in transcriptional activity, can influence the secretory activity of D148E.
There is dynamic crosstalk between APE1/Ref-1 and the intracellular acetylation system. APE1/Ref-1 is acetylated by histone acetyl transferase of p300 [22] and is deacetylated by Sirtuin-1, a protein deacetylase, associated with APE1/Ref-1 [23] . Moreover, APE1/Ref-1 can induce Sirtuin-1 activation via redox [24, 25] . Therefore, genetic variations in APE1/Ref-1 can influence intracellular acetylation status [9] . TSA is a well-known HDAC inhibitor and is used to induce the secretion of APE1/ Ref-1 in cultured cell systems [9] . In the present study, we successfully demonstrated that the secretory activity of APE1/Ref-1 D148E is greater than that of wild-type APE1/Ref-1, with basal acetylation levels in response to TSA, suggesting that the increased secretion of APE1/Ref-1 D148E may be due to increased sensitivity of intracellular acetylation by HDAC inhibitors. Our findings in this study regarding the secretory activity of APE1/Ref-1 D148E are important, as they may aid in understanding the potential role of fundamental genetic variants in the increased serologic APE1/Ref-1 levels observed in certain disorders like malignant tumors.
